+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients



Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients



Transplantation Proceedings 29(7): 2955-2957




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046572018

Download citation: RISBibTeXText

PMID: 9365627

DOI: 10.1016/s0041-1345(97)00743-4


Related references

FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis. Transplantation Proceedings 28(6): 3166-3168, 1996

Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Transplantation Proceedings 28(3): 1354-1355, 1996

Prospective trial of OKT3 for early prophylaxis of rejection in immunologic "high risk" renal transplant recipients: long-term results. Transplantation Proceedings 24(5): 1732-1733, 1992

OKT3 treatment of steroid-resistant rejection in pediatric liver transplant recipients. Journal of Pediatric Gastroenterology and Nutrition 14(1): 86-91, 1992

Predicting factors for long-term results of OKT3 therapy in steroid-resistant acute rejection following cadaveric renal transplantation. Transplantation Proceedings 30(4): 1170-1172, 1998

Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation. American Journal of Nephrology 19(6): 634-640, 1999

Predicting Factors of Long-Term Results of Okt3 Therapy for Steroid Resistant Acute Rejection following Cadaveric Renal Transplantation. American Journal of Nephrology 19(6): 634-640, 1999

Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Transplantation Proceedings 28(2): 1014, 1996

Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center. Transplantation Proceedings 31(7): 2870-2871, 1999

A comparison of outcomes between OKT3 and antithymocyte globulin for treatment of steroid-resistant rejection in hepatitis C liver transplant recipients. Transplantation 97(4): 470-473, 2014

Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection. Transplant International 7(4): 278-283, 1994

The effect of induction alg malg on the outcome of steroid resistant rejection treatment with okt3 in renal transplant patients. Transplantation Proceedings 23(1 BOOK 2): 1039-1040, 1991

Long-term results of OKT3-treated renal transplant recipients. Transplantation Proceedings 28(3): 1350-1351, 1996

Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection. Transplantation Proceedings 27(1): 1014-1015, 1995

Effectiveness of short-term OKT3 therapy in the treatment of steroid-resistant renal allograft rejection. Transplantation Proceedings 30(6): 2876-2877, 1998